Related Experiment Video
Updated: May 3, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Antibiotic-induced liver toxicity: mechanisms, clinical features and causality assessment
Mercedes Robles1, Elena Toscano, Judith Cotta
1Liver Unit, Gastroenterology Service and Department of Medicine, Vírgen de Victoria University Hospital, University of Málaga, Spain.
Abstract:
Antibiotics are the therapeutic agents most often associated with hepatotoxicity. However, this is mainly due to the widespread prescription of these drugs. The relative risk of antibiotic-related hepatotoxicity is low. Causality assessment of suspected drug-induced liver injury (DILI) related to antibiotics can be difficult, particularly because some cases occur long after the drug has been stopped. Among the penicillins, amoxicillin clavulanate is the most associated with hepatotoxicity and is the most frequent cause of DILI-related hospitalisations. Flucloxacillin ranks as the second highest cause of DILI in many countries. The severity of antibiotic-induced DILI varies widely, with the hepatitis-like (hepatocellular) damage tending to be more severe that than cholestatic/mixed type. The pattern is strongly influenced by age. Recently telithromycin (a new generation macrolide) has been linked with DILI, with a typical pattern, which includes abrupt commencement of fever, abdominal pain, jaundice and, in some cases, ascites. Antibiotic-induced DILI appears, in most instances, to be idiosyncratic. Genetic-association studies have recently identified genotypes related to flucloxacillin and possibly to amoxicillin-clavulanate hepatotoxicity.
Insights
Antibiotics can cause liver injury (hepatotoxicity), but the risk is low. Amoxicillin clavulanate and flucloxacillin are common culprits, with genetic factors potentially influencing susceptibility to antibiotic-induced liver damage.
Area of Science:
- Hepatology
- Pharmacology
- Toxicology
Background:
- Antibiotics are frequently linked to drug-induced liver injury (DILI).
- Widespread antibiotic use contributes to the high association, though the relative risk remains low.
- Assessing causality for antibiotic-induced DILI can be challenging due to delayed onset.
Purpose of the Study:
- To review the landscape of antibiotic-associated hepatotoxicity.
- To highlight specific antibiotics frequently implicated in DILI.
- To discuss the patterns, severity, and potential genetic underpinnings of antibiotic-induced liver injury.
Main Methods:
- Literature review of antibiotic-associated hepatotoxicity.
- Analysis of causality and patterns of drug-induced liver injury.
- Inclusion of recent findings on genetic associations with DILI.
Main Results:
- Amoxicillin clavulanate is the leading cause of antibiotic-related DILI hospitalizations, followed by flucloxacillin.
- Hepatocellular DILI is generally more severe than cholestatic/mixed types, with age influencing patterns.
- Telithromycin is a newer macrolide associated with a distinct DILI presentation.
- Antibiotic-induced DILI is often idiosyncratic, but genetic associations for flucloxacillin and amoxicillin-clavulanate are emerging.
Conclusions:
- While antibiotic-associated hepatotoxicity is a concern, the overall risk is low.
- Specific antibiotics like amoxicillin clavulanate and flucloxacillin pose a higher risk.
- Understanding idiosyncratic reactions and genetic predispositions is crucial for managing antibiotic-induced liver injury.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Drug Toxicity: Overview
Drug Toxicity: Risk factors
Drug Toxicity: Dose-Dependent Reactions
Drug toxicity: Idiosyncratic Reactions
Drug toxicity: Drug–Drug Interaction

